<H1>Chapter DOI: 10.1007/s00105-014-3570-0<br/>Cited-By Count: 2</H1><table border="1" width="30%"><tr><td>Total References</td><td>38</td></tr><tr><td>Springer references</td><td>4</td></tr><tr><td>Non Springer references</td><td>34</td></tr><tr><td>BibStructured Count</td><td width="10%">30</td></tr><tr><td>BibUnstructured Count</td><td width="10%">8</td></tr><tr><td>DOI already available in SpringerLink</td><td>28</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>8</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>7</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>7</td></tr><tr><td>Valid DOI Enriched</td><td>3</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Liu Z, Davidson A (2012) Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871&#8211;882</td><td><a href=http://dx.doi.org/10.1038/nm.2752>10.1038/nm.2752</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Kuhn A, Sticherling M, Bonsmann G (2007) Clinical manifestations of cutaneous lupus erythematosus. J Dtsch Dermatol Ges 5:1124&#8211;1137</td><td><a href=http://dx.doi.org/10.1111/j.1610-0387.2007.06554.x>10.1111/j.1610-0387.2007.06554.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Rhodes B, Vyse TJ (2008) The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 47:1603&#8211;1611</td><td><a href=http://dx.doi.org/10.1093/rheumatology/ken247>10.1093/rheumatology/ken247</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Moser KL, Kelly JA, Lessard CJ et al (2009) Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10:373&#8211;379</td><td><a href=http://dx.doi.org/10.1038/gene.2009.39>10.1038/gene.2009.39</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Smolen JS, Klippel JH, Penner E et al (1987) HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 46:457&#8211;462</td><td><a href=http://dx.doi.org/10.1136/ard.46.6.457>10.1136/ard.46.6.457</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Fousteri G, Liossis SN, Battaglia M (2013) Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol 149:556&#8211;565</td><td><a href=http://dx.doi.org/10.1016/j.clim.2013.10.006>10.1016/j.clim.2013.10.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Lopez P, Gomez J, Prado C et al (2008) Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35:1559&#8211;1566</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Roberts AL, Thomas ER, Bhosle S et al (2014) Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases. Arthritis Res Ther 16:R114</td><td><a href=http://dx.doi.org/10.1186/ar4566>10.1186/ar4566</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Shen N, Fu Q, Deng Y et al (2010) Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 107:15838&#8211;15843</td><td><a href=http://dx.doi.org/10.1073/pnas.1001337107>10.1073/pnas.1001337107</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Ramos PS, Shaftman SR, Ward RC et al (2014) Genes associated with SLE are targets of recent positive selection. Autoimmune Dis 2014:203435</td><td><a href=http://dx.doi.org/10.1155/2014/203435>10.1155/2014/203435</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, Year, VolumeID, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>McAdam RA, Goundis D, Reid KB (1988) A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual. Immunogenetics 27:259&#8211;264</td><td><a href=http://dx.doi.org/10.1007/BF00376120>10.1007/BF00376120</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Pickering MC, Botto M, Taylor PR et al (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227&#8211;324</td><td><a href=http://dx.doi.org/10.1016/S0065-2776(01)76021-X>10.1016/S0065-2776(01)76021-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Lee-Kirsch MA, Gong M, Schulz H et al (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet 79:731&#8211;737</td><td><a href=http://dx.doi.org/10.1086/507848>10.1086/507848</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Peschke K, Friebe F, Zimmermann N et al (2014) Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J Invest Dermatol 134:1456&#8211;1459</td><td><a href=http://dx.doi.org/10.1038/jid.2013.496>10.1038/jid.2013.496</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Lee-Kirsch MA, Chowdhury D, Harvey S et al (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 85:531&#8211;537</td><td><a href=http://dx.doi.org/10.1007/s00109-007-0199-9>10.1007/s00109-007-0199-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Ravenscroft JC, Suri M, Rice GI et al (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A 155A:235&#8211;237</td><td><a href=http://dx.doi.org/10.1002/ajmg.a.33778>10.1002/ajmg.a.33778</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Yang YG, Lindahl T, Barnes DE (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873&#8211;886</td><td><a href=http://dx.doi.org/10.1016/j.cell.2007.10.017>10.1016/j.cell.2007.10.017</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Stetson DB, Ko JS, Heidmann T et al (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587&#8211;598</td><td><a href=http://dx.doi.org/10.1016/j.cell.2008.06.032>10.1016/j.cell.2008.06.032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Ablasser A, Hemmerling I, Schmid-Burgk JL et al (2014) TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 192:5993&#8211;5997</td><td><a href=http://dx.doi.org/10.4049/jimmunol.1400737>10.4049/jimmunol.1400737</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Lee-Kirsch MA, Wolf C, Gunther C (2014) Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol 175:17&#8211;24</td><td><a href=http://dx.doi.org/10.1111/cei.12160>10.1111/cei.12160</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Goldstone DC, Ennis-Adeniran V, Hedden JJ et al (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379&#8211;382</td><td><a href=http://dx.doi.org/10.1038/nature10623>10.1038/nature10623</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Crow YJ, Hayward BE, Parmar R et al (2006) Mutations in the gene encoding the 3&#8216;&#8211;5&#8216; DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS 1 locus. Nat Genet 38:917&#8211;920</td><td><a href=http://dx.doi.org/10.1038/ng1845>10.1038/ng1845</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Rice GI, Kasher PR, Forte GM et al (2012) Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 44:1243&#8211;1248</td><td><a href=http://dx.doi.org/10.1038/ng.2414>10.1038/ng.2414</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Rice GI, del Toro DY, Jenkinson EM et al (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503&#8211;509</td><td><a href=http://dx.doi.org/10.1038/ng.2933>10.1038/ng.2933</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Crow YJ, Leitch A, Hayward BE et al (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38:910&#8211;916</td><td><a href=http://dx.doi.org/10.1038/ng1842>10.1038/ng1842</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Ramantani G, Kohlhase J, Hertzberg C et al (2010) Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome. Arthritis Rheum 62:1469&#8211;1477</td><td><a href=http://dx.doi.org/10.1002/art.27367>10.1002/art.27367</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Schmidt JL, Olivieri I, Vento JM et al (2012) Family history of autoimmune disease in patients with Aicardi-Goutieres syndrome. Clin Dev Immunol 2012:206730</td><td><a href=http://dx.doi.org/10.1155/2012/206730>10.1155/2012/206730</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Lee-Kirsch MA, Gong M, Chowdhury D et al (2007) Mutations in the gene encoding the 3&#8216;-5&#8216; DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065&#8211;1067</td><td><a href=http://dx.doi.org/10.1038/ng2091>10.1038/ng2091</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Al-Mayouf SM, Sunker A, Abdwani R et al (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43:1186&#8211;1188</td><td><a href=http://dx.doi.org/10.1038/ng.975>10.1038/ng.975</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Belot A, Kasher PR, Trotter EW et al (2013) Protein kinase cdelta deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum 65:2161&#8211;2171</td><td><a href=http://dx.doi.org/10.1002/art.38008>10.1002/art.38008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Gunther</span> <span style='background:#DDDDDD'>C</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Meurer</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Stein</span> <span style='background:#DDDDDD'>A</span></span> et al</aug> (<span style='background:#66FF66'>2009</span>) <span style='background:#CCCCFF'>Familial Chilblain Lupus - A Monogenic Form of Cutaneous Lupus Erythematosus due to a Heterozygous Mutation in TREX1</span>. <span style='background:#CCFF99'>Dermatology</span> <span style='background:#FFCC66'>219</span>(<span style='background:#C8BE84'>2</span>):<span style='background:#D279FF'>162&#8211;166</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR32</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Rice</span> <span style='background:#DDDDDD'>G</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Newman</span> <span style='background:#DDDDDD'>WG</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Dean</span> <span style='background:#DDDDDD'>J</span></span> et al</aug> (<span style='background:#66FF66'>2007</span>) <span style='background:#CCCCFF'>Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome</span>. <span style='background:#CCFF99'>Am J Hum Genet</span> <span style='background:#FFCC66'>80</span>:<span style='background:#D279FF'>811&#8211;815</span></td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1086/513443>10.1086/513443</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, Author_FamilyName_2, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR33</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Tungler</span> <span style='background:#DDDDDD'>V</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Silver</span> <span style='background:#DDDDDD'>RM</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Walkenhorst</span> <span style='background:#DDDDDD'>H</span></span> et al</aug> (<span style='background:#66FF66'>2012</span>) <span style='background:#CCCCFF'>Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome</span>. <span style='background:#CCFF99'>Br J Dermatol</span> <span style='background:#FFCC66'>167</span>:<span style='background:#D279FF'>212&#8211;214</span></td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/j.1365-2133.2012.10813.x>10.1111/j.1365-2133.2012.10813.x</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, Author_FamilyName_2, FirstPage</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sugiura</span> <span style='background:#DDDDDD'>K</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Takeichi</span> <span style='background:#DDDDDD'>T</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Kono</span> <span style='background:#DDDDDD'>M</span></span> et al</aug> (<span style='background:#66FF66'>2012</span>) <span style='background:#CCCCFF'>Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3'-repair exonuclease 1</span>. <span style='background:#CCFF99'>J Invest Dermatol</span> <span style='background:#FFCC66'>132</span>:<span style='background:#D279FF'>2855&#8211;2857</span></td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1038/jid.2012.210>10.1038/jid.2012.210</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, Author_FamilyName_2, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR35</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Abe</span> <span style='background:#DDDDDD'>J</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Izawa</span> <span style='background:#DDDDDD'>K</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Nishikomori</span> <span style='background:#DDDDDD'>R</span></span> et al</aug> (<span style='background:#66FF66'>2013</span>) <span style='background:#CCCCFF'>Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus</span>. <span style='background:#CCFF99'>Rheumatology (Oxford)</span> <span style='background:#FFCC66'>52</span>:<span style='background:#D279FF'>406&#8211;408</span></td><td><a href=http://dx.doi.org/10.1093/rheumatology/kes181>10.1093/rheumatology/kes181</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, JournalTitle, VolumeID, Author_FamilyName_1, Author_FamilyName_2, FirstPage</td><td>CrossRef</td></tr><tr><td>CR36</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Gunther</span> <span style='background:#DDDDDD'>C</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hillebrand</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Brunk</span> <span style='background:#DDDDDD'>J</span></span> et al</aug> (<span style='background:#66FF66'>2013</span>) <span style='background:#CCCCFF'>Systemic involvement in TREX1-associated familial chilblain lupus</span>. <span style='background:#CCFF99'>J Am Acad Dermatol</span> <span style='background:#FFCC66'>69</span>:<span style='background:#D279FF'>e179&#8211;e181</span></td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2013.04.020>10.1016/j.jaad.2013.04.020</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, Year, Author_FamilyName_2, FirstPage</td><td>CrossRef</td></tr><tr><td>CR37</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Yamashiro</span> <span style='background:#DDDDDD'>K</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Tanaka</span> <span style='background:#DDDDDD'>R</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Li</span> <span style='background:#DDDDDD'>Y</span></span> et al</aug> (<span style='background:#66FF66'>2013</span>) <span style='background:#CCCCFF'>A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus</span>. <span style='background:#CCFF99'>J Neurol</span> <span style='background:#FFCC66'>260</span>:<span style='background:#D279FF'>2653&#8211;2655</span></td><td><a href=http://dx.doi.org/10.1007/s00415-013-7084-y>10.1007/s00415-013-7084-y</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, Year, FirstPage, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR38</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Gunther</span> <span style='background:#DDDDDD'>C</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Berndt</span> <span style='background:#DDDDDD'>N</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Wolf</span> <span style='background:#DDDDDD'>C</span></span> et al</aug> (<span style='background:#66FF66'>2014</span>) <span style='background:#FFD9B3'>Familial Chilblain Lupus Due to a Novel Mutation in the Exonuclease III Domain of 3' Repair Exonuclease 1 (TREX1)</span> . JAMA Dermatol, epub</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1001/jamadermatol.2014.3438>10.1001/jamadermatol.2014.3438</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2</td><td>CrossRef</td></tr></table>